- Country: Kazakhstan
- Summary: Drug Substances (Atropine Sulfate, Diphenhydramine, Suxamethonia, Mannitol, Dexamethasone, Etamsylate), Amt:
- KZT Ref No: 108585093
- Deadline: 18 Oct 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KZT 87342.60
- Notice Type: Tender
- Document Ref. No.: 13199105-1
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lots: Etamzilat - Solution for injection 12.5%, No. 1 | Dexamethasone - Solution for injection 4 mg/ml 1 ml, No. 25 | Mannitol - Solution for infusion, 15%, 200 ml, No. 1 | Diphenhydramine - Solution for injection, 1%, 1 ml, No. 10 | Atropine sulfate - Solution for injection 1 mg/ml 1 ml No. 10 | Suxamethonium chloride - Solution
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDrug Substances (Atropine Sulfate, Diphenhydramine, Suxamethonia, Mannitol, Dexamethasone, Etamsylate), Amt: - Kazakh Tender
The STATE UTILITY ENTERPRISE WITH THE RIGHT OF ECONOMIC MANAGEMENT "CITY HOSPITAL NO. 2" OF THE HEALTH DEPARTMENT OF THE CITY OF SHYMKENT, a Government sector organization in Kazakhstan, has announced a new tender for Drug Substances (Atropine Sulfate, Diphenhydramine, Suxamethonia, Mannitol, Dexamethasone, Etamsylate), Amt:. This tender is published on KazakhTenders under KZT Ref No: 108585093 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-10-18.
The estimated tender value is KZT 87342.60, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
